New DaVita Phosphorus Challenge tool for CKD and dialysis patients

NewsGuard 100/100 Score

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the launch of the DaVita Phosphorus Challenge™ (www.davita.com/phosphoruschallenge), an online resource designed to serve as a core learning tool for CKD and dialysis patients.

“The DaVita Phosphorus Challenge provides kidney disease patients and their care giving teams an easy to use tool that enables all patients to take an active role in their health care.”

The DaVita Phosphorus Challenge is a one-of-a-kind 30-day interactive challenge geared toward kidney disease and dialysis patients, care givers and related health care professionals. The challenge aims to educate users about phosphorus, its effects on those with CKD, the role of phosphorus binders and how to make smart food choices.

People with kidney disease are urged to eat foods that are low in phosphorus to help keep the blood level of phosphorus and parathyroid hormone in a healthy range. Unhealthy kidneys are no longer able to remove phosphorus from the blood and get rid of it through the urine. High levels of phosphorus are a greater problem for people with stage 4 and 5 kidney disease, however people in earlier stages of CKD also benefit from a reduced phosphorus intake.

"DaVita continues to create new ways to educate the kidney care community about how they can lead healthier lives," said Kent Thiry, Chairman and Chief Executive Officer of DaVita®. "The DaVita Phosphorus Challenge provides kidney disease patients and their care giving teams an easy to use tool that enables all patients to take an active role in their health care."

DaVita Phosphorus Challenge participants receive a series of e-mails filled with links to games, quizzes and other interactive activities to better enhance patients' knowledge of phosphorus and its importance in their care. The DaVita Phosphorus Challenge helps turn the topic of phosphorus into a fun learning experience so patients can gauge what foods are low or high in phosphorus, among other topics.

High-risk groups for kidney disease include African-Americans, Hispanics, Pacific Islanders, Native Americans and seniors (those 60 and over). Primary risk factors include diabetes, hypertension, cardiovascular disease and a family history of these conditions. A silent epidemic, CKD affects 31 million, or one in six, Americans, with most unaware that they have the disease. The chance that an American adult has CKD is nearly 12 times greater than an American woman's risk of getting breast cancer.

DaVita has numerous programs like the DaVita Phosphorus Challenge that increase awareness, promote early detection and deliver disease management solutions for kidney disease patients. These programs, in conjunction with non-profit organizations like The Kidney TRUST™, which was founded and initially funded by DaVita, were created to help spread much-needed awareness and education about kidney disease throughout the United States.

DaVita and DaVita Phosphorus Challenge are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NYU Langone surgeons perform first combined mechanical heart pump and gene-edited pig kidney transplant surgery